Novozymes Biopharma unveils animal-free cell culture supplements

Published: 29-Sep-2008
Manufacturing

Novozymes Biopharma, specialists in large-scale recombinant protein production for the biopharmaceutical industry, has unveiled the first product under the CellPrime brand.


Novozymes Biopharma, specialists in large-scale recombinant protein production for the biopharmaceutical industry, has unveiled the first product under the CellPrime brand.

Novozymes" Transferrin recombinant supplement is now commercially ready in scalable manufacturing quantities for consistency of supply. Designed to reduce risk and ease regulatory concerns for biopharmaceutical manufacturers, this new advance will improve the consistency and productivity of customers" industrial cell culture process.

Manufactured by Novozymes Biopharma, Transferrin is sold exclusively through Millipore Corporation.

See more

You may also like

Manufacturing

GSK uses Novozymes\' Veltis half-life extension technology in once-weekly diabetes drug

Read more
Novozymes technology used in recently approved Eperzan type 2 diabetes treatment

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

GSK uses Novozymes\' Veltis half-life extension technology in once-weekly diabetes drug

Novozymes technology used in recently approved Eperzan type 2 diabetes treatment
Manufacturing

LIVE FROM CPHI: Novozymes Biopharma to collaborate with Almac

In drug manufacture, half life extension and targeting technologies
Manufacturing

Novozymes utilises wastewater to produce biogas

New shared biogas reactor produces as much electricity as seven offshore wind turbines, reduces carbon dioxide emissions and lowers energy costs
Manufacturing

Repligen to buy Novozymes Biopharma Sweden

Creates leading supplier of products for manufacturing biologic drugs
Manufacturing

SAFC and Novozymes extend growth factor agreement

Offers increased cell density, higher viability and extended culture duration
Manufacturing

Hyaluronic acid - the biotech way

<p>Fanny Longin, science manager, Novozymes Biopolymer, reveals why a new biotech method of producing hyaluronic acid is proving to be a winner </p>
Manufacturing

Sapio Sciences introduces world’s first 3rd-generation ELN

Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
Subscribe now